107 related articles for article (PubMed ID: 7243447)
1. Fatal graft versus host disease following a blood transfusion in a child with neuroblastoma.
Woods WG; Lubin BH
Pediatrics; 1981 Feb; 67(2):217-21. PubMed ID: 7243447
[TBL] [Abstract][Full Text] [Related]
2. Fatal graft-versus-host disease after a small leukocyte transfusion in a patient with lymphoma and varicella.
Betzhold J; Hong R
Pediatrics; 1978 Jul; 62(1):63-6. PubMed ID: 28510
[TBL] [Abstract][Full Text] [Related]
3. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Prevention of graft-vs.-host disease.
Woods WG
Am J Pediatr Hematol Oncol; 1984; 6(3):283-6. PubMed ID: 6393792
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature.
Decoste SD; Boudreaux C; Dover JS
Arch Dermatol; 1990 Oct; 126(10):1324-9. PubMed ID: 2221937
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of transfusion-associated graft-versus-host disease.
Yasuda H; Ohto H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):69-75. PubMed ID: 7927137
[TBL] [Abstract][Full Text] [Related]
6. Unrelated, HLA-mismatched multiple human umbilical cord blood transfusion in four cases with advanced solid tumors: initial studies.
Shen BJ; Hou HS; Zhang HQ; Sui XW
Blood Cells; 1994; 20(2-3):285-92. PubMed ID: 7749108
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo-expanded donor CD4(+) lymphocyte infusion against relapsing neuroblastoma: A transient graft-versus-tumor effect.
Yoshida H; Kusuki S; Hashii Y; Ohta H; Morio T; Ozono K
Pediatr Blood Cancer; 2009 Jul; 52(7):895-7. PubMed ID: 19191346
[TBL] [Abstract][Full Text] [Related]
8. [Human umbilical cord blood transplantation in 4 cases with advanced solid tumors].
Shen BJ
Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):152-4. PubMed ID: 7900979
[TBL] [Abstract][Full Text] [Related]
9. Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease.
Park BH; Good RA; Gate J; Burke B
Transplant Proc; 1974 Dec; 6(4):385-7. PubMed ID: 4155155
[No Abstract] [Full Text] [Related]
10. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of post-transfusion graft-versus-host disease after formalin-fixation.
Ryo R; Goto M; Takada M; Saigo K; Yamaguchi N; Hayashi M; Ito H; Onoyama H; Saito Y; Uchida S
Int J Hematol; 1994 Jun; 59(4):297-302. PubMed ID: 8086623
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
13. An autopsy report of graft-versus-host disease (GVHD) following blood transfusion.
Otori K; Masuda C; Wanibuchi H; Nakanishi A; Kawabata K; Ohashi H; Fukushima S
Osaka City Med J; 1999 Jun; 45(1):37-43. PubMed ID: 10723200
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of stage IV neuroblastoma with allogeneic hematopoietic stem cell transplantation in children].
Lu QY; Wang Z; Li P; Niu XQ; Zhang P; Zhao JN
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):464-6. PubMed ID: 18706162
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-associated graft-versus-host disease.
Ohmori K; Sato H; Furukawa H; Sagara H; Kanno M
Fukushima J Med Sci; 1993 Dec; 39(2):89-94. PubMed ID: 7927139
[TBL] [Abstract][Full Text] [Related]
17. Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion.
Amrolia PJ; Rao K; Slater O; Ramsay A; Veys PA; Webb DK
Bone Marrow Transplant; 2001 Sep; 28(6):623-5. PubMed ID: 11607779
[TBL] [Abstract][Full Text] [Related]
18. Transfusion in transplant patients: the good, the bad, and the ugly.
Klein HG
J Heart Lung Transplant; 1993; 12(1 Pt 1):S7-12. PubMed ID: 8443186
[TBL] [Abstract][Full Text] [Related]
19. [Graft vs host reaction after blood transfusion in a child with a primary defect of cellular immunity].
Bernatowska E; Rujner J; Michałkiewicz J; Grajkowska W; Wiernicka J
Pol Tyg Lek; 1987 Jul; 42(30):918-20. PubMed ID: 3499602
[No Abstract] [Full Text] [Related]
20. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
